RamsdenDBHoffenbergR. The transport of the thyroid hormones. Clin Sci.1983; 65: 337–42.
2.
PartridgeWM. Transport of protein-bound hormones into tissues in vivo. Endoc Rev1981; 2: 103–23.
3.
EkinsRPEdwardsPNewmanB. The role of the binding proteins in hormone delivery. In: AlbertiniAEkinsRP, eds. Free hormones in blood. Amsterdam: Elsevier Biomedical Press, 1982; 3–26.
4.
ClarkFHornDB. Assessment of thyroid function by the combined use of the serum protein-bound iodine and resin uptake of 131I-triiodothyronine. J Clin Endocrinol Metab1965; 25: 39–45.
5.
MidgleyJEMWilkinsTA. New methods of free thyroid hormone assay. In: BizollonCh A, ed. Physiological Peptides and New Trends in Radioimmunoassay. Amsterdam: Elsevier North Holland, 1981; 215–34.
6.
MidgleyJEMWilkinsTA. An improved method for the estimation of relative binding constants of T4 and its analogues with serum proteins. Clin Endocrinol1982; 17: 523–8.
7.
MidgleyJEMWilkinsTA. A defense of the Amerlex free thyroxine kit. Clin Chem.1982; 28: 2183–4.
8.
MidgleyJEMWilkinsTA. Lancet.1982; ii: 712–3.
9.
ForfarJCToftAD. Thyrotoxic atrial fibrillation: an under-diagnosed condition?Brit Med J1982; 285: 909–10.
10.
RobbinsJJohnsonML. Theoretical considerations in the transport of the thyroid hormones in blood. In: EkinsRPFagliaGPennisiFPincheraA, eds. International Symposium on Free Thyroid Hormones, Venice 1978. Amsterdam: Excerpta Medica, 1979; 1–14.
11.
FranklynJASheppardMCRamsdenDBWilkinsonRHoffenbergR. Measurement of free thyroxine and free triiodothyronine in thyrotoxicosis and hypothyroidism. Clin Endocrinol1984; 20: 107–10.
12.
MahlstedtJ. Measurement of free L-triiodothyronine in serum—results of a multicentre trial. Nuc Compact1983; 14: 280–97.
13.
SethJKellettHACaldwellGSweetingVMBeckettGJCowSMToftAD. A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyro-trophin releasing hormone test?Brit Med J1984; 289: 1334–5.
14.
PearceCJRinslerMG. Unpublished observations.
15.
ChopraIJHershmanJMPardridgeMDNicoloffJT. Thyroid function in non-thyroidal illness. Ann Int Med.1983; 98: 946–57.
16.
PearceCJ. Unpublished observations.
17.
LarsenPRSilvaJEKaplanMM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endoc Rev1982; 2: 87–102.
18.
PearceCJHimsworthRL. Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine. Brit Med J1984; 288: 693–5.
19.
PrinceHP. Ramsden DB. A new theoretical description of the binding of thyroid hormones by serum proteins. Clin Endocrinol1977; 7: 307–24.
20.
AshwellKHoptonMRHarropJS. Serum free thyroxine concentrations in subjects with high circulating levels of thyroxine-binding globulin. Ann Clin BioChem.1983; 20: 285–8.
21.
FranklynJASheppardMCRamsdenDBHoffenbergR. Free triiodothyronine and free thyroxine in sera of pregnant women and subjects with congenitally increased or decreased thyroxine-binding globulin. Clin Chem.1983; 29: 1527–30.
22.
WhitworthASMidgleyJEMWilkinsTA. A comparison of free T4 and the ratio of total T4 to T4-binding globulin in serum through pregnancy. Clin Endocrinol1982; 17: 307–13.
23.
MidgleyJEMWilkinsTAGilesAFWhitworthAS. Free T4 levels in patients receiving anticonvulsant, salicylate and phenylbutazone therapy. Acta Endocrinologica Congress, 1981; abstract.
24.
RatcliffeWAHazeltonRAThomsonJARatcliffeJG. The effect of fenclofenac on thyroid function tests in vivo andin vitro. Clin Endocrinol1980; 13: 569–77.
25.
TaylorRClarkFGriffithsIDWeckeJ. prospective study of the effect of fenclofenac on thyroid function tests. Brit Med J1982; 281: 911–2.
26.
WilkinsTAMidgleyJEMGilesAF. Treatment with heparin and results for free thyroxin: an in vivo or an in vitro effect?Clin Chem.1982; 28: 2441–43.
27.
LambertMJBurgerAGGaleazziRLEnglerD. Are selective increases in serum thyroxine due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism?J Clin Endoc Metab1982; 55: 1058–65.
28.
ByfieldPGHLallozMRAPearceCJHimsworthRL. Free thyroid hormone concentrations in subjects with various abnormalities of binding proteins: experience with Amerlex free T4 and free T3 assays. Clin Endocrinol1983; 19: 277–83.
29.
StockigtJRStevensVWhiteELBarlowJW. ‘Unbound analog’ radioimmunoassays for free thyroxin measure the albumin bound fraction. Clin Chem.1983; 29: 1408–10.
30.
WilkeTJ. Study of a mechanism responsible for anomalous results for free thyroxin by some analog assays for subjects with albumin deficiency. Clin Chem.1984; 30: 1742–5.
31.
PlattHSBarronNGilesAFMidgleyJEMWilkinsTA. Thyroid function parameters in an analbuminemic subject on thyroxin therapy for hypothyroidism. Clin Chem.1985; 31: 341–2.
32.
AminoNNishiKNakataniKMizutaHIchiharaKTamzawaOMiyoiK. Effect of albumin concentration on the assay of serum free thyroxin by equilibrium radioimmunoassay with labelled thyroxine analog. Clin Chem.1983; 29: 321–5.
33.
BayerMF. Free thyroxine results are affected by albumin concentration and non-thyroidal illness. Clin Chim Acta1983; 130: 391–6.
34.
LallozMRAByfieldPGHHimsworthRL. A prealbumin variant with an increased affinity for T4 and reverse T3. Clin Endocrinol1984; 21: 331–8.
35.
ByfieldPGH. Unpublished observations.
36.
LallozMRAByfieldPGHHimsworthRL. Hyperthyroxinaemia: abnormal binding of T4 by an inherited albumin variant. Clin Endocrinol1983; 18: 11–24.
37.
LallozMRAByfieldPGHHimsworthRL. A new and distinctive albumin variant with increased affinities for both triiodothyronines and causing hyperthyroxinaemia. Clin Endocrinol1985; 22: 521–9.
38.
StockigtJRWhiteELBarlowJW. Differences between familial hyperthyroxinaemic syndromes. New Engl J Med.1982; 307: 824–5.
39.
MosesACLawlorJHaddonJJacksonI. Differences between familial hyperthyroxinaemic syndromes. New Engl J Med.1982; 307: 825.
40.
DickMWatsonF. A possible variant of TBG in Australian aborigines. Clin Chim Acta1981; 116: 361–7.
41.
Beck-PeccozPRomelliPBCattaneoMGFagliaGWhiteELBarlowJWStockigtJR. Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies. J Clin Endocrinol Metab1984; 58: 736–9.
42.
AllanDJMurphyFNeedhamCABarronNWilkinsTAMidgleyJEM. A sensitive test for thyroid hormone autoantibodies in serum. Lancet.1982; ii: 824.
43.
FieldingAM. Prevalence of serum autoantibody binding of Amerlex thyroxin analog. Clin Chem.1984; 30: 501–2.
44.
MullingerRNWalkerG. Free thyroxin in thyroid disease. Clin Chem.1982; 28: 1394–5.
45.
IsozakiOTsushimaTSatoKSajiMOhbaYEmotoNSatoYShizumeK. Triiodothyronine binding immunoglobulin in a euthyroid man without apparent thyroid disease; properties and effects on triiodothyronine metabolism. Acta Endo1985; 108: 498–503.
46.
ByfieldPGHBondACoppingSHimsworthRL. Restricted antigenicity of thyroxyls in human thyroglobulin. Biochem J1982; 207: 471–8.
47.
JansenMKrenningEPOostdijkWDocterRKingmaBEvan den BrandeJVLHennemannG. Hyperthyroxinaemia due to decreased peripheral triiodothyronine production. Lancet.1982; ii: 849–51.